22 Nov Company seeking to treat autism-related impairments receives $200K investment from IU fund
Confluence Pharmaceuticals develops treatments for social and communication impairments related to autism spectrum disorder, fragile X syndrome April 11, 2019 The Indiana University Philanthropic Venture Fund, which invests in IU-related ventures, has invested $200,000 in Confluence Pharmaceuticals LLC. Confluence Pharmaceuticals is a Carmel, Indiana-based company that develops novel, clinically discovered,...
